Matzen S, Knigge U, Warberg J
Institute of Medical Physiology C, Panum Institute, University of Copenhagen, Denmark.
Neuroendocrinology. 1990 Aug;52(2):175-80. doi: 10.1159/000125570.
The possible involvement of histamine (HA) in the stress-induced increase in plasma renin activity (PRA) was investigated in male rats. Intracerebroventricular (ICV) infusion of histamine (HA; 3.8-60 micrograms) increased PRA dose-dependently, and the Kd (dissociation konstant) of HA was estimated to approximately 30 micrograms. ICV infusion of HA (30 micrograms) as well as 5 min of restraint stress increased plasma renin activity (PRA) 2- and 3-fold, respectively (p less than 0.01). These effects were abolished by prior ICV infusion of the H2-receptor antagonists cimetidine (100 micrograms) and ranitidine (125 micrograms) (p less than 0.01), which reduced the PRA to subbasal levels (p less than 0.05). When administered alone the H2-receptor antagonists had no effect on PRA. In contrast, the H1-receptor antagonist mepyramine (100 micrograms) increased the basal PRA level (p less than 0.01) and slightly augmented the HA- and stress-induced increase in PRA (p less than 0.05). HA as well as restraint stress increased the plasma levels of dopamine, norepinephrine and epinephrine almost 2-fold (p less than 0.01). The effect of the two stimuli was prevented by prior ICV infusion of mepyramine or cimetidine (p less than 0.01). Pretreatment with the beta-adrenergic receptor blocker propranolol (7 mg/kg i.p.) abolished the HA-induced and inhibited by 70% the stress-induced PRA increase. The results indicate that histaminergic neurons participate in the cerebral regulation of renin secretion. The H2-receptor-mediated PRA-increasing effect of HA involves activation of sympathetic nerves. In addition, HA seems to exert a minor inhibiting effect on PRA via H1-receptors.
在雄性大鼠中研究了组胺(HA)可能参与应激诱导的血浆肾素活性(PRA)升高的情况。脑室内(ICV)注入组胺(HA;3.8 - 60微克)可使PRA呈剂量依赖性增加,HA的Kd(解离常数)估计约为30微克。ICV注入HA(30微克)以及5分钟的束缚应激分别使血浆肾素活性(PRA)增加2倍和3倍(p < 0.01)。预先ICV注入H2受体拮抗剂西咪替丁(100微克)和雷尼替丁(125微克)可消除这些作用(p < 0.01),这将PRA降低至基础水平以下(p < 0.05)。单独给予H2受体拮抗剂时对PRA无影响。相反,H1受体拮抗剂美吡拉敏(100微克)可提高基础PRA水平(p < 0.01),并轻微增强HA和应激诱导的PRA升高(p < 0.05)。HA以及束缚应激可使多巴胺、去甲肾上腺素和肾上腺素的血浆水平几乎增加2倍(p < 0.01)。预先ICV注入美吡拉敏或西咪替丁可阻止这两种刺激的作用(p < 0.01)。用β肾上腺素能受体阻滞剂普萘洛尔(7毫克/千克,腹腔注射)预处理可消除HA诱导的PRA升高,并使应激诱导的PRA升高受到70%的抑制。结果表明组胺能神经元参与肾素分泌的脑调节。HA的H2受体介导的PRA升高作用涉及交感神经的激活。此外,HA似乎通过H1受体对PRA发挥轻微的抑制作用。